Chief Outsiders Augments Northeast Tribe with Addition of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Chief Outsiders Augments Northeast Tribe with Addition of Company Growth Accelerator John Bischoff

NEW YORK, Jan. 6, 2016 (GLOBE NEWSWIRE) -- Fractional CMO leader Chief Outsiders has further expanded its Northeast Tribe in the new year, announcing the addition of mid-size company growth expert John Bischoff to the organization. Bischoff, a national and international marketing executive with an accomplished career that spans a comprehensive portfolio of industries, is ready to offer powerful yet sustainable growth solutions to today's mid-sized company CEO. With core expertise in the development, implementation, measurement, and monitoring of specific marketing and sales initiatives to achieve targeted company goals, Bischoff is an excellent asset to company executives seeking clarity about how to maximize growth potential within a company's existing infrastructure and resources. Furthermore, Bischoff is adept at identifying improvement areas and introducing additional opportunities for companies looking to diversify or expand within, or beyond, their core markets. "John is an excellent addition to the Northeast tribe, with an unmatched combination of proven experience, and insightful, future-forward leadership in a variety of industries, both domestically and internationally," said Slade Kobran, managing partner for Chief Outsiders' Northeast region. "With his track record, John is ideally suited to help mid-size company CEOs transition their visions to reality – partnering with them to help identify needed organizational change in order to stimulate profitable growth." All Chief Outsiders tribe members have held the position of CMO or VP of Marketing at one or more operating companies. Bischoff's impressive track record in industries that include cable television, security, and travel and tourism are evidence of his ability to contribute from day one, working to provide simplified, strategic solutions to complex marketing challenges. Bischoff began his career in the accelerated management programs of New York Telephone and AT &T, quickly developing his knack for strategic planning and marketing. Other assignments that expanded Bischoff's strategic footprint included turns as Chief Executive Officer of the BISCH Group, Vice President of International Brand Strategy for the Las Vegas Convention & Visitors Authority, and Chief Marketing Officer for St. Moritz Security Services. At St. Moritz, Bischoff led a remarketing and rebranding strategy that included sales initiatives – delivering a dynamic plan that helped accelerate the company's growth past its $50M annual revenue goal. During Bischoff's tenure, St. Moritz received national ranking among the nation's top 20 leading security enterprises. While with the Las Vegas Convention & Visitors Authority, Bischoff's international brand strategy resulted in unprecedented increases in visitors from outside the United States – a feat which contributed hundreds of millions of incremental dollars to the local economy. Bischoff earned a Bachelor of Science in Management from St. Francis College in Brooklyn, NY, and an MBA in International Marketing and Finance from Fordham University. He also holds an Executive Certification in Computer Technology from NYU. Bischoff is available immediately to serve CEOs looking for growth acceleration guidance. About Chief Outsiders Chief Outsiders, LLC, an "Executives-as-a-Service" firm, helps grow mid-sized companies from coast-to-coast with nearly 50 part-time, or fractional, Chief Marketing Officers (CMOs) who have held positions of VP Marketing or higher at one or more operating companies. These individuals' breadth of experience makes it possible for Chief Outsiders to put the right skill set on a leadership team of any company for a fraction of the cost of a full time executive. Unlike other strategic marketing and management consulting firms, Chief Outsiders works with company leadership teams to develop and implement market based growth plans. Chief Outsiders believes delivering a world-class marketing strategy on its own creates little value and that the real value is created by helping the organization implement the growth vision. Because of its market based growth plans, leadership and experienced team, Chief Outsiders was recently listed by Inc Magazine as one of the 1,000 fastest growing privately held companies in the US (in the top 25 in Houston) and recognized for the Houston Business Journal's Fast 100 . Businesses seeking Chief Outsiders as a premier source include: ErgoGenesis, Five Stone Tax, Summa Technologies, and Riverside Company portfolio companies OnCourse Learning, YourMembership and IDoc, Source Capital portfolio companies such as Abutec, and Merrill Lynch Specialties Group portfolio companies such as EarthColor.  

A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38354

Sterling Wilkinson, 817-771-2997,

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading